Table 3.

Inflammation Scores from Clinical Observation Using Indirect Ophthalmoscope

	Inflammation score
Treatment regimen	Conjunctival injection	Anterior chamber	Vitreous
Group 1 (n = 8): Control - No treatment	0.9 ± 0.8	0.5 ± 0.5	3.3 ± 1.1
Group 2 (n = 3): 15% DSP, 15 min, 4 doses	0.5 ± 0.4a	0.1 ± 0.2b	0.4 ± 1.0b
Group 3 (n = 2): 15% DSP, 10 min, 1 dose	0.3 ± 0.4b	0.1 ± 0.2b	0.6 ± 1.2b
Group 4 (n = 3): 8% DSP, 10 min, 1 dose	0.5 ± 0.5a	0.3 ± 0.4a	0.4 ± 0.8b
Group 5 (n = 3): 8% DSP, 5 min, 4 doses	0.9 ± 0.8 (P = 0.3)	0.5 ± 0.5 (P = 0.6)	1.4 ± 1.7b
Group 6 (n = 3): 4% DSP, 10 min, 2 doses	0.5 ± 0.5c	0.4 ± 0.6 (P = 0.1)	1.4 ± 1.6b

Statistical differences in the average scores observed between the control group and each DSP-Visulex treatment group were assessed by the Wilcoxon rank-sum test with ^aP < 0.01, ^bP < 0.001, and ^cP < 0.05.